Able Laboratories to Report 2002 Fourth Quarter and Year-End Financial Results on Wednesday, March 5, 2003.

Business Editors/Health/Medical Writers

SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Feb. 28, 2003

Able Laboratories, Inc. (Nasdaq:ABRX, BSE:AAB), today announced that it will release its 2002 fourth quarter and year-end financial results prior to market opening on March 5, 2003. Coinciding with this announcement, the Company has scheduled a conference call and web cast at 10:30 a.m. Eastern Time, or 7:30 a.m. Pacific Time. To participate in the conference call, please call 888/803-8276 in the U.S., or 706/634-8102 internationally. A telephone replay will be made available for 48 hours following the call by dialing 800/642-1687 in the U.S., or 706/645-9291 internationally and entering reservation number 8820427.

Individuals interested in listening to the conference call via the Internet may do so by visiting the web site http://www.ablelabs.com. A replay will be made available on the web site for 90 days.

Able Laboratories is a developer and manufacturer of generic pharmaceuticals. Since March 2001, Able has received 24 ANDA approvals. Further information on Able may be found on the Company's web site, www.ablelabs.com.

Except for historical facts, the statements in this news release, as well as oral statements or other written statements made or to be made by Able Laboratories, Inc., are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties. For example, statements about the Company's operations, capital-raising transactions and financial accounting, the current or expected market size for its products, the success of current or future product offerings, the research and development efforts and the Company's ability to file for and obtain U.S. Food and Drug Administration approvals for future products, are forward-looking statements. Forward-looking statements are merely the Company's current predictions of future events. The statements are inherently uncertain, and actual results could differ materially from the statements made herein. There is no assurance that the Company will achieve the sales levels that will make its operations profitable or that ANDA filings and approvals will be completed and obtained as anticipated. For a description of additional risks, and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2001 and its Form 10-Q for the six months ended June 30, 2002. The Company assumes no obligation to update its forward-looking statements to reflect new information and developments.